CITrials CEO, Debra Hoffmeyer Conducts a Global Meet Discussing the Impact of COVID-19 Crisis on Clinical Trials
Debra Hoffmeyer, CEO & Founder of CITrials, recently conducted a Zoom meeting with many key leaders and stakeholders in global clinical research to discuss the impact of COVID-19 crisis on the clinical trial industry. In this global meet, Debra discussed continuing clinical trials, continuity and contingency plans, and ensuring stability and infrastructure for sites during this coronavirus pandemic. The meeting was attended by major pharmaceutical companies like Eli Lilly, Intra-Cellular Therapies, Acadia Pharmaceuticals, Otsuka Pharmaceuticals, BMS Pharma Cervelo Pharmaceuticals, FDA,...
View full press release